M.E. Allison & CO. Inc. Purchases Shares of 860 Intuitive Surgical, Inc. (NASDAQ:ISRG)

M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 860 shares of the medical equipment provider’s stock, valued at approximately $449,000.

Other hedge funds also recently added to or reduced their stakes in the company. Mirador Capital Partners LP lifted its stake in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares in the last quarter. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Consolidated Planning Corp increased its holdings in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 73.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after buying an additional 114,149 shares during the last quarter. Finally, Czech National Bank increased its holdings in shares of Intuitive Surgical by 6.9% during the 4th quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider’s stock worth $40,309,000 after buying an additional 4,970 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 1.5 %

Intuitive Surgical stock opened at $592.64 on Monday. The stock has a market cap of $211.09 billion, a P/E ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The company has a fifty day simple moving average of $540.66 and a 200-day simple moving average of $499.19. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ISRG shares. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. BTIG Research lifted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. This trade represents a 26.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 48,190 shares of company stock valued at $25,012,927. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.